20624-87-7

Basic information

• Product Name: 3-CHLORO-4 5-DIMETHOXYBENZOIC ACID 97
• Synonyms: 3-CHLORO-4 5-DIMETHOXYBENZOIC ACID 97;3-Chloro-4,5-dimethoxybenzoic acid 97%
• CAS NO: 20624-87-7
• Molecular Formula: C₉H₉ClO₄
• Molecular Weight: 216.619
• Product Categories: C9;Carbonyl Compounds;Carboxylic Acids
• Mol File: 20624-87-7.mol
• Article Data: 2

Chemical Properties

• Melting Point: 189-193 °C(lit.)
• Boiling Point: 328.5°Cat760mmHg
• Flash Point: 152.5°C
• Appearance: /
• Density: 1.337g/cm³
• Vapor Pressure: 7.62E-05mmHg at 25°C
• Refractive Index: 1.548
• CAS DataBase Reference: 3-CHLORO-4 5-DIMETHOXYBENZOIC ACID 97(CAS DataBase Reference)
• NIST Chemistry Reference: 3-CHLORO-4 5-DIMETHOXYBENZOIC ACID 97(20624-87-7)
• EPA Substance Registry System: 3-CHLORO-4 5-DIMETHOXYBENZOIC ACID 97(20624-87-7)

Safety Data

• Safety Statements: 22-24/25
• WGK Germany: 3
• Hazardous Substances Data: 20624-87-7(Hazardous Substances Data)

Usage

General Description

3-Chloro-4,5-dimethoxybenzoic acid 97 is a chemical compound with the molecular formula C10H9ClO4. 3-CHLORO-4 5-DIMETHOXYBENZOIC ACID 97 is a white solid and is typically used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals. It is also used as a reagent in organic synthesis to introduce the 3-chloro-4,5-dimethoxyphenyl group into molecules. Additionally, this compound has been studied for its potential anti-inflammatory and anti-cancer properties. Due to its versatile applications in the pharmaceutical and agrochemical industries, 3-chloro-4,5-dimethoxybenzoic acid 97 is a valuable and important chemical compound.

InChI:InChI=1/C9H9ClO4/c1-13-7-4-5(9(11)12)3-6(10)8(7)14-2/h3-4H,1-2H3,(H,11,12)

Upstream product

• 90537-30-7 5-chloro-3,4-dimethoxybenzonitrile 
• 93-07-2 Veratric acid 
• 18268-68-3 5-chloroveratraldehyde 

Downstream Products

• 1181450-42-9 C₉H₈Cl₂O₃ 
• 132496-77-6 methyl 3,4-dihydroxy-5-chlorobenzoate 
• 132496-78-7 Methyl 5-chloro-3,4-di-p-methoxybenzyloxybenzoate 
• 1338708-61-4 3-chloro-4,5-bis((4-methoxybenzyl)oxy)-N-(2-(pyrrolidin-1-yl)ethyl)benzamide 
• 1623785-45-4 2-(3-chloro-4,5-dimethoxybenzyl)-7-methoxy-6-(triisopropylsilyloxy)-1,2,3,4-tetrahydroisoquinoline 
• 1623785-57-8 2-(3-chloro-4,5-dimethoxybenzyl)-7-methoxy-6-sulfamoyloxy-1,2,3,4-tetrahydroisoquinoline 
• 1623785-51-2 2-(3-chloro-4,5-dimethoxybenzyl)-6-hydroxy-7-methoxy-1,2,3,4-tetrahydroisoquinoline 
• 1623785-72-7 2-(3-chloro-4,5-dimethoxybenzoyl)-6-hydroxy-1,2,3,4-tetrahydroisoquinoline 

Relevant articles and documents

Synthesis and biological activities of new halophenols

A series of new halophenols were synthesized, and their structures were established on the basis of 1H, 13C NMR and mass spectral data. All of the prepared compounds were screened for their in vitro protein tyrosine kinase (PTK) and vascular smooth muscle cell (VSMC) proliferation inhibitory activity. Twelve halophenols showed significant PTK inhibitory activity, most of them exhibited stronger activities than that of genistein, a positive reference compound. Several halophenols also displayed moderate VSMC proliferation inhibitory activity, compound 8c showed higher activity than that of tetrandrine, a positive reference compound. The preliminary structure-activity relationships of these compounds were investigated and discussed. The results provided a foundation for the action mechanism study and further structure optimization of the halophenols.